CDKN2A and cancer: To assess if the pattern of tumor gene expression in the parental cancer cells could be returned to a comparatively benign states, we analysed the expression of two tumor suppressors (p19ARFand p16INK4a) and two oncogenes (Bcl2 and C-fos).